Javier Martín Broto
Hospital Universitario Fundación Jiménez Díaz · Hospital Fundación Jiménez Díaz · GEIS (GRUPO ESPAÑOL DE INVESTIGACION EN SARCOMAS
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Javier Martín Broto as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:36 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05809830 · Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue SarcomasGrupo Espanol de Investigacion en Sarcomas · active not recruiting · Advanced Soft-tissue Sarcoma · principal investigator
- Ph1/Ph2NCT05146440 · Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid TumorGrupo Espanol de Investigacion en Sarcomas · recruiting · Advanced Soft-tissue Sarcoma, Advanced L-sarcomas, Other Advanced Sarcomas · study director
- Ph2NCT05131386 · Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic SarcomasGrupo Espanol de Investigacion en Sarcomas · unknown · Soft Tissue Sarcoma, Bone Tumors, Small Round-cell Sarcomas · study director
- Ph1NCT04595994 · Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and OsteosarcomaGrupo Espanol de Investigacion en Sarcomas · unknown · Sarcoma,Soft Tissue · study director
- Ph1/Ph2NCT03277924 · Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone SarcomasGrupo Espanol de Investigacion en Sarcomas · completed · Soft Tissue Sarcoma, Bone Sarcoma · study director
- Ph2NCT03242382 · Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.Grupo Espanol de Investigacion en Sarcomas · unknown · Soft-tissue Sarcoma, Osteosarcoma, Chordoma · principal investigator
- Ph2NCT02638766 · Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GISTGrupo Espanol de Investigacion en Sarcomas · completed · Gastrointestinal Stromal Tumors · study chair
- Ph1/Ph2NCT02275286 · Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma PatientsGrupo Espanol de Investigacion en Sarcomas · recruiting · Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:36 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- 374 citationsRCR 14.4
- 136 citationsRCR 4.6
- 43 citationsRCR 2.8
- Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial.Cancer · 202530 citationsRCR 7.6
- CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study.Cancer Med · 202327 citationsRCR 2.5
- Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study.Invest New Drugs · 20146 citationsRCR 0.2
- 6 citationsRCR 1.6